BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

903 related articles for article (PubMed ID: 18951117)

  • 1. Treatment of diabetes mellitus using an external insulin pump in clinical practice.
    Jeandidier N; Riveline JP; Tubiana-Rufi N; Vambergue A; Catargi B; Melki V; Charpentier G; Guerci B
    Diabetes Metab; 2008 Sep; 34(4 Pt 2):425-38. PubMed ID: 18951117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
    Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
    Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained metabolic control and low rates of severe hypoglycaemic episodes in preschool diabetic children treated with continuous subcutaneous insulin infusion.
    Pańkowska E; Szypowska A; Lipka M; Skórka A
    Acta Paediatr; 2007 Jun; 96(6):881-4. PubMed ID: 17537017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion].
    Szypowska A; Pańkowska E; Lipka M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):45-50. PubMed ID: 16704861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII).
    Shashaj B; Busetto E; Sulli N
    Diabet Med; 2008 Sep; 25(9):1036-42. PubMed ID: 18937673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New strategies for glucose control in patients with type 1 and type 2 diabetes mellitus in pregnancy.
    Gabbe SG; Carpenter LB; Garrison EA
    Clin Obstet Gynecol; 2007 Dec; 50(4):1014-24. PubMed ID: 17982345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes.
    Lee SW; Cao M; Sajid S; Hayes M; Choi L; Rother C; de León R
    Diabetes Nutr Metab; 2004 Aug; 17(4):211-6. PubMed ID: 15575341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin pump use in adults with type 1 diabetes--practical issues.
    Shetty G; Wolpert H
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S11-6. PubMed ID: 20515299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin pump therapy in adults.
    Didangelos T; Iliadis F
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S109-13. PubMed ID: 21864741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Education of the patient for therapy with personal insulin pump].
    Benbenek-Klupa T
    Przegl Lek; 2006; 63(5):292-5. PubMed ID: 17036508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New methods in insulin treatment].
    Neuwirth G
    Orv Hetil; 2005 Jan; 146(3):111-6. PubMed ID: 15693442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Children and adolescents on intensive insulin therapy maintain postprandial glycaemic control without precise carbohydrate counting.
    Smart CE; Ross K; Edge JA; Collins CE; Colyvas K; King BR
    Diabet Med; 2009 Mar; 26(3):279-85. PubMed ID: 19317823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin pump therapy and rapid acting insulin: what have we learned?
    Zinman B
    Int J Clin Pract Suppl; 2001 Sep; (123):47-50. PubMed ID: 11594299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
    Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
    Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rediscovery of insulin pump treatment of childhood type 1 diabetes.
    Weinzimer SA; Doyle EA; Steffen AT; Sikes KA; Tamborlane WV
    Minerva Med; 2004 Apr; 95(2):85-92. PubMed ID: 15272243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Personal insulin pumps--from experiment research till recommended method of diabetes treatment].
    Mozdzan M; Ruxer J; Loba J
    Pol Merkur Lekarski; 2005 Oct; 19(112):577-9. PubMed ID: 16379330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When to treat a diabetic patient using an external insulin pump. Expert consensus. Société francophone du diabète (ex ALFEDIAM) 2009.
    Lassmann-Vague V; Clavel S; Guerci B; Hanaire H; Leroy R; Loeuille GA; Mantovani I; Pinget M; Renard E; Tubiana-Rufi N;
    Diabetes Metab; 2010 Feb; 36(1):79-85. PubMed ID: 20074990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients].
    Li M; Zhou J; Bo YQ; Lu W; Jia WP; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1679-82. PubMed ID: 19024537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.